Ameren Corp
F:AE4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Ameren Corp
F:AE4
|
US |
|
B
|
BAWAG Group AG
VSE:BG
|
AT |
|
B
|
BioCryst Pharmaceuticals Inc
XMUN:BO1
|
US |
Wall St Price Targets
AE4 Price Targets Summary
Ameren Corp
According to Wall Street analysts, the average 1-year price target for AE4 is 94.9 EUR with a low forecast of 82.46 EUR and a high forecast of 110.91 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AE4's stock price target?
Price Target
94.9
EUR
According to Wall Street analysts, the average 1-year price target for AE4 is 94.9 EUR with a low forecast of 82.46 EUR and a high forecast of 110.91 EUR.
What is the Revenue forecast for Ameren Corp?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 5 years is 7%.
What is the Gross Profit forecast for Ameren Corp?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 5 years is 3%.
What is the Operating Income forecast for Ameren Corp?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 5 years is 12%.
What is the Pre-Tax Income forecast for Ameren Corp?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 5%. The projected CAGR for the next 3 years is 11%.
What is the Net Income forecast for Ameren Corp?
Projected CAGR
10%
The compound annual growth rate for Net Income over the next 5 years is 10%.
